Complete Your Journey To Therapeutic Success: End-To-End Solutions And Support To Bridge Every Gap In Your Peptide Characterizations

Bringing a therapeutic peptide to market requires reliable characterization from raw materials through final product release. Explore integrated workflows for purity and impurity analysis, sequence and structure confirmation, aggregate analysis, bioanalysis, stability testing, and purification. Agilent combines advanced analytical solutions with method development, training, compliance, maintenance, relocation, enterprise services, and digital connectivity to support consistent results across laboratories. Flexible financial options can also help organizations align technology investments with scientific and business priorities.

See how end-to-end capabilities and expert support can help close workflow gaps, improve operational efficiency, and move therapeutic peptide programs toward key development milestones with greater confidence.